Last ¥2,130 JPY
Change Today +22.00 / 1.04%
Volume 321.9K
4541 On Other Exchanges
Symbol
Exchange
OTC US
Tokyo
As of 1:00 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

nichi-iko pharmaceutical co (4541) Snapshot

Open
¥2,130
Previous Close
¥2,108
Day High
¥2,146
Day Low
¥2,112
52 Week High
01/30/15 - ¥2,146
52 Week Low
05/21/14 - ¥1,403
Market Cap
129.2B
Average Volume 10 Days
277.4K
EPS TTM
¥105.53
Shares Outstanding
60.7M
EX-Date
03/27/15
P/E TM
20.2x
Dividend
¥24.60
Dividend Yield
1.15%
Current Stock Chart for NICHI-IKO PHARMACEUTICAL CO (4541)

Related News

No related news articles were found.

nichi-iko pharmaceutical co (4541) Related Businessweek News

No Related Businessweek News Found

nichi-iko pharmaceutical co (4541) Details

Nichi-Iko Pharmaceutical Co., Ltd. is engaged in the manufacture, sale, distribution, export, import, and related activities for various pharmaceuticals. The company primarily focuses on the production of generic drugs. It also offers treatments for circulatory, digestive, respiratory, and central and peripheral nervous system disorders. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was founded in 1965 and is headquartered in Toyama, Japan.

926 Employees
Last Reported Date: 06/20/14
Founded in 1965

nichi-iko pharmaceutical co (4541) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nichi-iko pharmaceutical co (4541) Key Developments

Nichi-Iko Pharmaceutical Co., Ltd. Presents at Nomura Investment Forum 2014, Dec-02-2014

Nichi-Iko Pharmaceutical Co., Ltd. Presents at Nomura Investment Forum 2014, Dec-02-2014 . Venue: The Palace Hotel Tokyo, Tokyo, Japan.

Nichi-Iko Pharmaceutical Co., Ltd. Reports Consolidated Earnings Results for the Second Quarter Ended September 30, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015

Nichi-Iko Pharmaceutical Co., Ltd. reported consolidated earnings results for the second quarter ended September 30, 2014. For the quarter, the company reported net sales of JPY 60,949 million against JPY 49,526 million a year ago. Operating income was JPY 4,410 million against JPY 3,718 million a year ago. Ordinary income was JPY 4,370 million against JPY 3,613 million a year ago. Net income was JPY 3,007 million against JPY 2,244 million a year ago. Net income per share was JPY 50.29 against JPY 56.32 a year ago. Diluted net income per share was JPY 50.25 against JPY 56.27 a year ago. For the year ending March 31, 2015, the company expects net sales of JPY 123,000 million, operating income of JPY 9,300 million, ordinary income of JPY 9,000, and net income of JPY 5,900 million or net income per share of JPY 98.67.

Nichi-Iko Pharmaceutical Co., Ltd. to Report Q2, 2015 Results on Nov 05, 2014

Nichi-Iko Pharmaceutical Co., Ltd. announced that they will report Q2, 2015 results on Nov 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4541:JP ¥2,130.00 JPY +22.00

4541 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4541.
View Industry Companies
 

Industry Analysis

4541

Industry Average

Valuation 4541 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NICHI-IKO PHARMACEUTICAL CO, please visit www.nichiiko.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.